Clean Harbors Inc (CLH) · Aug 12, 2026 · Acquisition
$470M acquisition — All-cash purchase; approximately 9x post-synergy Adjusted EBITDA
Clean Harbors adds a recurring-revenue environmental platform at a stated 9x post-synergy multiple, but the upside depends on execution.
There is no clean consensus benchmark for this private-company acquisition. The relevant test is whether the price, target quality and synergy case look disciplined relative to Clean Harbors’ stated acquisition strategy—not whether the company’s presentation sounds optimistic. The filing provides no transaction-specific earnings estimate from analysts or prior public guidance, so this is not a conventional beat-or-miss event.
| Metric | Disclosure | Derived read |
|---|---|---|
| Purchase price | $470M cash | — |
| Revenue | ~$250M annually | ~1.9x revenue |
| Adjusted EBITDA | ~$27M annually | ~17.4x pre-synergy EBITDA |
| Cost synergies | ~$25M over two years | Nearly doubles stated EBITDA |
| Post-synergy EBITDA | — | ~$52M implied; ~9x multiple |
| Recurring revenue | 85% | Supports revenue durability |
The asset itself is strategically credible, but the valuation is ordinary before synergies. EnviroServe brings 40 locations, permits in 48 states, 18 transfer facilities, more than 2,500 customers and recurring revenue representing 85% of sales (Company overview; Financial details). Those assets fit Clean Harbors’ technical-services, disposal, recycling and field-services network. But paying roughly 17.4 times the target’s stated standalone EBITDA is not obviously cheap; the investment case depends heavily on capturing the projected $25M of cost savings.
The synergy case is the entire swing factor. If the $25M estimate is achieved, the implied purchase multiple falls to approximately 9 times EBITDA, and management says the deal should become meaningfully accretive to earnings and cash flow (Financial details; Management commentary). That is potentially constructive, but the filing gives no timetable beyond the first two years, no integration-cost estimate, no financing detail and no quantified earnings-per-share contribution. The claimed accretion therefore remains a management projection rather than a demonstrated result.
Net read: strategically sensible, but not an unambiguous bargain. The transaction is new information and adds a sizable, recurring-revenue platform, yet the disclosed economics are only compelling after execution of a synergy plan that nearly doubles current target EBITDA. With no outside consensus to beat, the filing lands as a mixed acquisition read: credible strategic fit, meaningful upside if synergies materialize, and limited proof so far that the premium standalone price is justified.
Regulatory approval and closing expected in the second half of 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!